Applied Therapeutics, Inc. (NASDAQ:APLT) stock is trading lower on Thursday, with a session volume of 20.07 million, compared to its average volume of 4.88 million, according to Benzinga Pro.The company provided an update on regulatory strategy for Govorestat for Charcot-Marie-Tooth Sorbitol Dehydrogenase Deficiency (CMT-SORD) following receipt of Type C meeting minutes.CMT-SORD is a genetic defect that prevents the body from metabolizing sorbitol, leading to its toxic buildup in cells and the resulting dam ...